Avanos Medical

AVNS

Market cap $1.15B

Avanos Medical agrees to be acquired by the private-equity firm American Industrial Partners in an all-cash deal worth $1.27 billion.

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Avanos Medical, Inc. (NYSE:  AVNS )  related to its sale to affiliates of American Industrial Partners.

MILWAUKEE, April 14, 2026 /PRNewswire/ -- Ademi LLP is investigating Avanos (NYSE: AVNS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with American Industrial. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners for $25.00 per share in cash.Halper Sadeh encourages Avanos shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Avanos and its board of.

Avanos ​Medical said ‌on Tuesday ​it ​has agreed ⁠to ​be ​bought by affiliates ​of ​American Industrial Partners (AIP) ‌in ⁠an all-cash ​deal ​worth ⁠about $1.27 billion.

Avanos Stockholders To Receive $25.00 Per Share in Cash ALPHARETTA, Ga. and NEW YORK, April 14, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced it has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners ("AIP"), an operationally-oriented industrials investor, in an all-cash transaction that values Avanos at an enterprise value of approximately $1.272 billion.

AVNS gains on strong SNS and PMR growth, M&A and cost actions, but tariff risks and segment headwinds may weigh on near-term performance.

NEW YORK, March 17, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Avanos Medical, Inc. (NYSE: AVNS) on behalf of the company's shareholders.  The investigation seeks to determine whether Avanos Medical's directors breached their fiduciary duties in connection with recent corporate actions.

Avanos Medical, Inc. (AVNS) Presents at The Citizens Life Sciences Conference 2026 Transcript

ALPHARETTA, Ga., March 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer, will participate in a fireside chat at the 2026 Citizens Life Sciences Conference on Wed.